Insider Transactions in Q1 2023 at Exelixis, Inc. (EXEL)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2023
|
Jack L Wyszomierski Director |
SELL
Open market or private sale
|
Direct |
15,300
-4.6%
|
$244,800
$16.61 P/Share
|
|
Mar 10
2023
|
Jack L Wyszomierski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+10.73%
|
$240,000
$6.3 P/Share
|
|
Mar 01
2023
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
77,860
-12.86%
|
$1,323,620
$17.13 P/Share
|
|
Mar 01
2023
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
27,860
+4.4%
|
$390,040
$14.74 P/Share
|
|
Feb 28
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Open market or private sale
|
Direct |
82,490
-19.01%
|
$1,402,330
$17.5 P/Share
|
|
Feb 28
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Exercise of conversion of derivative security
|
Direct |
82,490
+15.97%
|
$1,154,860
$14.74 P/Share
|
|
Feb 27
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Open market or private sale
|
Direct |
10
-0.0%
|
$170
$17.5 P/Share
|
|
Feb 27
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Exercise of conversion of derivative security
|
Direct |
10
+0.0%
|
$140
$14.74 P/Share
|
|
Feb 21
2023
|
Alan M Garber Director |
SELL
Open market or private sale
|
Direct |
40,000
-56.01%
|
$680,000
$17.49 P/Share
|
|
Feb 21
2023
|
Alan M Garber Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+35.9%
|
$240,000
$6.3 P/Share
|
|
Feb 15
2023
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
1,556
-0.61%
|
$28,008
$18.08 P/Share
|
|
Feb 15
2023
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,522
-3.38%
|
$207,396
$18.08 P/Share
|
|
Feb 15
2023
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,929
-0.33%
|
$34,722
$18.08 P/Share
|
|
Feb 15
2023
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,278
-1.04%
|
$95,004
$18.08 P/Share
|
|
Feb 15
2023
|
Vicki L Goodman EVP, Prod Dev & Med Aff &CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,299
-7.14%
|
$311,382
$18.08 P/Share
|
|
Feb 15
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
1,529
-0.43%
|
$27,522
$18.08 P/Share
|
|
Feb 09
2023
|
Carl B Feldbaum Director |
SELL
Open market or private sale
|
Direct |
40,000
-68.14%
|
$680,000
$17.78 P/Share
|
|
Feb 09
2023
|
Carl B Feldbaum Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+40.53%
|
$240,000
$6.3 P/Share
|
|
Feb 06
2023
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
25,000
-8.95%
|
$425,000
$17.37 P/Share
|
|
Feb 06
2023
|
Patrick J. Haley EVP, Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+8.21%
|
$100,000
$4.2 P/Share
|
|
Jan 30
2023
|
Michael Morrissey President and CEO |
BUY
Bona fide gift
|
Indirect |
37,994
+2.76%
|
-
|
|
Jan 30
2023
|
Michael Morrissey President and CEO |
SELL
Bona fide gift
|
Direct |
37,994
-10.03%
|
-
|
|
Jan 24
2023
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
62,006
-14.07%
|
$1,054,102
$17.36 P/Share
|
|
Jan 24
2023
|
Michael Morrissey President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+18.5%
|
$400,000
$4.2 P/Share
|
|
Jan 05
2023
|
Dana Aftab CSO/EVP Disc & Trans Research |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+22.08%
|
-
|